Travere Therapeutics Inc (TVTX) — Capital Reinvestment Ratio
Travere Therapeutics Inc (TVTX) has a Capital Reinvestment Ratio of 0.01x as of December 2025, meaning it reinvests 0% of its operating cash flow ($60.68 Million) in capital expenditures ($375.00K). See TVTX net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Travere Therapeutics Inc Capital Reinvestment Ratio (2017–2025)
This chart tracks Travere Therapeutics Inc's Capital Reinvestment Ratio across 2 annual periods. Check TVTX capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Travere Therapeutics Inc (2017–2025)
Year-by-year Capital Reinvestment Ratio for Travere Therapeutics Inc from 2017 to 2025. For live market cap and broader valuation context, see how much is Travere Therapeutics Inc worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.54x | $37.78 Million | $58.16 Million | ▼ -18.7% |
| 2017 | 1.89x | $7.40 Million | $14.01 Million | — |